CNS Pharmaceuticals, Inc.
Develops anti-cancer drug candidates for cancers of the brain and nervous system.
CNSP | US
Overview
Corporate Details
- ISIN(s):
- US18978H1023
- LEI:
- Country:
- United States of America
- Address:
- 2100 WEST LOOP SOUTH, 77027 HOUSTON
- Website:
- https://cnspharma.com/
- Sector:
- Manufacturing
Description
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company that develops anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The company's primary focus is on glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer. Its lead drug candidate, Berubicin, is an anthracycline designed to cross the blood-brain barrier, a significant challenge in treating CNS tumors. The company's technology aims to enable therapeutics to penetrate the brain and directly target tumors.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all CNS Pharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CNS Pharmaceuticals, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CNS Pharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
